Latest news
Clarity Pharmaceuticals reports clinical trial milestones - The Motley Fool AustraliaThe Motley Fool Australia · Thu, 06 Aug 2026 00:32:00 GMTAre Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%? - The Motley Fool AustraliaThe Motley Fool Australia · Wed, 05 Aug 2026 20:34:42 GMTClarity Pharmaceuticals reports two more complete responses in prostate cancer trial - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMTClarity Pharmaceuticals Reports Further Strong Efficacy and Favourable Safety from SECuRE Prostate Cancer Trial - Finance News NetworkFinance News Network · Wed, 05 Aug 2026 02:30:29 GMTClarity Pharmaceuticals reports new SECuRE trial responses at higher dose - The Motley Fool AustraliaThe Motley Fool Australia · Wed, 05 Aug 2026 01:02:13 GMTClarity Pharmaceuticals Reports Two New Complete Responses in SECuRE Trial 8 GBq Dose Cohorts - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMTNeuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade - The Motley Fool AustraliaThe Motley Fool Australia · Wed, 05 Aug 2026 00:19:28 GMTWhy this ASX healthcare stock is at the cusp of a 'Transformational Opportunity' – Expert - The Motley Fool AustraliaThe Motley Fool Australia · Tue, 04 Aug 2026 23:50:04 GMT